Fate Therapeutics (FATE) Tops Q2 EPS by 5c, misses on revenue

Go back to Fate Therapeutics (FATE) Tops Q2 EPS by 5c, misses on revenue
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.11 +0.14 (7.11%)
Previous Close $1.97    52 Week High $4.76 
Open $2.00    52 Week Low $1.46 
Day High $2.14    P/E N/A 
Day Low $1.99    EPS $-1.91 
Volume 477,043